Prediction
Okay, so I need to help modify the eligibility criteria for the clinical trial based on the supporting evidence provided.
The original eligibility criteria were from Version 3 of the OptiMize trial, but now there's new supporting evidence from a study called Shared Responsibility for Medication Use for People with Dementia and General Health Conditions (SRMUDGHC).
First, I should read through the provided supporting evidence to understand the key points.
The SRMUDGHC study emphasizes patient-centered care, involves the patient and caregiver in medication management, and focuses on deprescribing.
It found that patients and caregivers are enthusiastic about deprescribing, and it's scalable across different primary care settings.
Looking at the original eligibility criteria, they include a lot of standard patient characteristics, like age, cognitive status, medication count, etc.
But the new evidence suggests that the intervention is more effective when patients and caregivers are actively involved, and the setting is a primary care clinic.
So, the modified criteria should reflect these changes.
I should consider updating the inclusion criteria to focus more on the patient's willingness to engage in deprescribing, perhaps by including a question about their preference for medication management.
Also, the exclusion criteria might need to be adjusted to better reflect the study's focus on primary care settings and patient engagement.
I also notice that the original criteria mention a MCI/dementia cohort and a non-dementia cohort, which is good.
I should ensure that the new criteria maintain this distinction but perhaps refine the inclusion/exclusion based on the SRMUDGHC findings.
Another point is the need to ensure that the study complies with the updated IRB number, which is IRB00253480.
I should check if the criteria need to reference this number or if it's sufficient to mention the updated version.
I should also make sure that the criteria are clear and that all necessary documentation is included, like EHR records and letters from general practice physicians.
This ensures that the study can be conducted effectively.
Finally, I need to present the modified criteria in a clear, organized manner, using the same structure as the original but updated with the new evidence.
This includes patient inclusion, caregiver eligibility, and exclusion criteria, all aligned with the SRMUDGHC study's approach.
</think>
**Modified Eligibility Criteria for the OptiMize Trial (Version 4)**
**Patient Inclusion Criteria:**
1.
**Age:** Patients must be 65 years of age or older.
2.
**Cognitive Impairment or Dementia:** Patients must have a diagnosis of dementia, Alzheimer's disease, or other forms of cognitive impairment, as confirmed by ICD-10 or ICD-11 codes on their problem list or through a cognitive impairment assessment.
3.
**Medication Use:** Patients must currently be taking 5 or more different medications for all their health conditions, documented in their electronic medical records (EMR).
4.
**Primary Care Visit:** Patients must have a scheduled primary care visit at the pilot clinic within the study period.
5.
**Willingness to Engage in Deprescribing:** Patients must be willing to discuss medication discontinuation with their primary care physician and caregivers, as supported by the SRMUDGHC study.
6.
**Documentation:** Eligible patients must have documentation from their general practice physician or primary care physician attesting to their ability to manage their medication use.
**Caregiver Eligibility Criteria:**
1.
**Age:** Caregivers must be 21 years of age or older.
2.
**Willingness to Engage in Deprescribing:** Caregivers must be willing to discuss medication discontinuation with their primary care physician, as supported by the SRMUDGHC study.
3.
**Documentation:** Caregivers must have documentation from their primary care physician attesting to their willingness to engage in deprescribing.
**Exclusion Criteria:**
1.
**Residential Care Facilities or Hospice Care:** Patients or caregivers currently residing in long-term care facilities or enrolled in hospice care will be excluded.
2.
**Fewer Than 5 Medications:** Patients or caregivers with fewer than 5 different medications for all their health needs will be excluded.
3.
**Medical Eligibility Issues:** Patients or caregivers with significant medical issues that preclude participation in the study, as determined by the research team.
4.
**Cognitive Impairment or Dementia:** Caregivers or patients with cognitive impairment or dementia will be excluded.
5.
**Primary Care Provider Restrictions:** Primary care physicians or medical assistants who have been excluded from the study will not be eligible to participate.
**Study Compliance:**
- The study must be conducted under the updated IRB number (IRB00253480) to ensure compliance with institutional review board guidelines.
**Additional Considerations:**
- **Patient-Centered Care:** The criteria emphasize patient and caregiver engagement, aligning with the SRMUDGHC study's focus on shared decision-making for medication management.
- **Primary Care Focus:** The study is designed to be scalable across diverse primary care settings, ensuring broad applicability.
- **Documentation Requirements:** Detailed documentation from primary care providers is required to ensure eligibility and compliance with study standards.
This updated criteria ensures that the study aligns with the SRMUDGHC study's approach, focusing on patient-centered deprescribing and scalable implementation in primary care.